Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis-Reference-Cited by-同舟云学术

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

Published:2002-02 Issue:4 Volume:9 Page:291-296
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Liu S-C,Minton NP,Giaccia AJ,Brown JM

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301659.pdf

Reference23 articles.

1. Minton N.P. et al. Chemotherapeutic tumour targeting using clostridial spores FEMS Microbiol Rev 1995 17: 357 357

2. Fox M.E. et al. Anaerobic bacteria as a delivery system for cancer gene therapy: activation of 5-fluorocytosine by genetically engineered clostridia Gene Therapy 1996 3: 173 173

3. Lemmon M.L. et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment Gene Therapy 1997 4: 791 791

4. Malmgren R.A., Flanigan C.C. . Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration Cancer Res 1955 15: 473 473

5. Möse J.R., Möse G. . Onkolyseversuche mit apathogenen anaeroben Sporenbildern am Ehrlich Tumor des Maus Z Krebsforsch 1959 63: 63 63

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of bacteria-nanomaterial hybrids in antitumor therapy;Journal of Nanobiotechnology;2024-09-04

2. Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response;Cancer Communications;2024-08

3. Polymer–drug and polymer–protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination;Microbial Cell Factories;2024-04-24

5. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy;Advanced Materials;2024-03-04